Brain MRI changes in phenylketonuria. Associations with dietary status

A J Thompson1, S Tillotson, I Smith

  • 1Institute of Neurology, University College, London, UK.

Insights

Phenylketonuria (PKU) patients, even with early treatment, often show MRI-detected white matter changes. High phenylalanine levels and treatment withdrawal are linked to these brain abnormalities, suggesting a lifelong risk.

Area of Science:

  • Neurology
  • Biochemistry
  • Medical Imaging

Background:

  • Neonatal screening and early dietary treatment for phenylketonuria (PKU) have reduced neurological dysfunction.
  • Subtle neurological impairment and white matter abnormalities on MRI persist in some early-treated PKU subjects.
  • The frequency and relationship of white matter changes to dietary management in PKU remain unclear.

Purpose of the Study:

  • To investigate the frequency and characteristics of MRI-detected white matter abnormalities in individuals with phenylketonuria.
  • To determine the association between these abnormalities and factors like phenylalanine levels and dietary treatment adherence.

Main Methods:

  • Magnetic Resonance Imaging (MRI) was used to examine brain structure in 34 subjects with phenylketonuria (aged 8-33 years).
  • Subjects included those detected by neonatal screening and those missed by the program.
  • Dietary phenylalanine intake and phenylalanine concentrations were assessed.

Main Results:

  • Twenty-five of 34 subjects showed abnormalities on MRI.
  • In early-diagnosed subjects, MRI change severity correlated significantly with phenylalanine levels and time since dietary treatment withdrawal.
  • These findings align with animal studies showing phenylalanine's dose-dependent effect on myelin turnover.

Conclusions:

  • White matter abnormalities are common in phenylketonuria, even with early treatment.
  • Elevated phenylalanine levels and treatment cessation are linked to these changes, indicating a potential lifelong risk to myelin.
  • Phenylalanine's impact on myelin suggests ongoing neurotoxicity in PKU.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...